Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

Literature DB >> 18313171

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

Alexa B Kimball¹, Dafna Gladman, Joel M Gelfand, Kenneth Gordon, Elizabeth J Horn, Neil J Korman, Gretchen Korver, Gerald G Krueger, Bruce E Strober, Mark G Lebwohl.

Abstract

There have been several articles and reports in recent months about comorbidities and risks that affect psoriasis patients in addition to their underlying disease. This piece reviews the current literature and begins to address what should be done with this new information by updating the clinician about what health screening tests, preventative exams, and referrals should be considered in this population.

Entities: Disease Species

Mesh：

Year: 2008 PMID： 18313171 PMCID： PMC3716382 DOI： 10.1016/j.jaad.2008.01.006

Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527

138 in total

1. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.

Authors: J R Abrams; M G Lebwohl; C A Guzzo; B V Jegasothy; M T Goldfarb; B S Goffe; A Menter; N J Lowe; G Krueger; M J Brown; R S Weiner; M J Birkhofer; G L Warner; K K Berry; P S Linsley; J G Krueger; H D Ochs; S L Kelley; S Kang
Journal: J Clin Invest Date: 1999-05 Impact factor: 14.808

2. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis.

Authors: Oded Kimhi; Dan Caspi; Natan M Bornstein; Nitsan Maharshak; Alexander Gur; Yaron Arbel; Doron Comaneshter; Daphna Paran; Irena Wigler; David Levartovsky; Shlomo Berliner; Ori Elkayam
Journal: Semin Arthritis Rheum Date: 2006-10-25 Impact factor: 5.532

3. Infectious complications of erythrodermic psoriasis.

Authors: M S Green; J H Prystowsky; S R Cohen; J I Cohen; M G Lebwohl
Journal: J Am Acad Dermatol Date: 1996-05 Impact factor: 11.527

4. Surgery in patients with psoriasis and arthritis.

Authors: J R Lambert; V Wright
Journal: Rheumatol Rehabil Date: 1979-02

5. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis.

Authors: Gerald G Krueger; Kim A Papp; Dow B Stough; Keith H Loven; Wayne P Gulliver; Charles N Ellis
Journal: J Am Acad Dermatol Date: 2002-12 Impact factor: 11.527

6. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.

Authors: A Hannuksela; E Pukkala; M Hannuksela; J Karvonen
Journal: J Am Acad Dermatol Date: 1996-11 Impact factor: 11.527

7. Hyperuricemia in psoriatic arthritis: prevalence and associated features.

Authors: I N Bruce; C T Schentag; D D Gladman
Journal: J Clin Rheumatol Date: 2000-02 Impact factor: 3.517

8. Alcohol intake and treatment responsiveness of psoriasis: a prospective study.

Authors: M A Gupta; N J Schork; A K Gupta; C N Ellis
Journal: J Am Acad Dermatol Date: 1993-05 Impact factor: 11.527

9. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

Authors: D D Gladman; V T Farewell; K Wong; J Husted
Journal: Arthritis Rheum Date: 1998-06

10. An Italian study on psoriasis and depression.

Authors: Maria Esposito; Rosita Saraceno; Alessandro Giunta; Mara Maccarone; Sergio Chimenti
Journal: Dermatology Date: 2006 Impact factor: 5.366

88 in total

Review 1. FOCUS ON PSORIASIS: A REPORT FROM THE 73RD ANNUAL MEETING OF THE AMERICAN ACADEMY OF DERMATOLOGYPsoriasis-related topics included targeted therapies, safety of biologies, comorbidities.

Authors: Jessica M Donigan
Journal: J Clin Aesthet Dermatol Date: 2015-07

2. Psoriasis and cardiovascular risk: strength in numbers, part II.

Authors: Joel M Gelfand; Nehal N Mehta; Sinéad M Langan
Journal: J Invest Dermatol Date: 2011-05 Impact factor: 8.551

3. A practical approach to monitoring patients on biological agents for the treatment of psoriasis.

Authors: Jason J Emer; Amylynne Frankel; Joshua A Zeichner
Journal: J Clin Aesthet Dermatol Date: 2010-08

Review 4. Update on the natural history and systemic treatment of psoriasis.

Authors: Stephen K Richardson; Joel M Gelfand
Journal: Adv Dermatol Date: 2008

5. Diet and weight loss as a treatment for psoriasis.

Authors: Joel M Gelfand; Katrina Abuabara
Journal: Arch Dermatol Date: 2010-05

Review 6. Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.

Authors: Teo Soleymani; Soumya M Reddy; Jeffrey M Cohen; Andrea L Neimann
Journal: Curr Rheumatol Rep Date: 2017-11-20 Impact factor: 4.592

7. Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2014 MauiDerm Meeting.

Authors: Neal Bhatia; Andrew Blauvelt; Marc Brown; Whitney High; Craig T Leonardi; Ted Rosen; Linda Stein Gold; Eggert Stockfleth; Bruce Strober; Neil A Swanson; George Martin
Journal: J Clin Aesthet Dermatol Date: 2014-07

8. Biologic safety in psoriasis: review of long-term safety data.

Authors: Yasaman Mansouri; Gary Goldenberg
Journal: J Clin Aesthet Dermatol Date: 2015-02

9. Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.

Authors: Howa Yeung; Joy Wan; Abby S Van Voorhees; Kristina Callis Duffin; Gerald G Krueger; Robert E Kalb; Jamie D Weisman; Brian R Sperber; Bruce A Brod; Stephen M Schleicher; Bruce F Bebo; Daniel B Shin; Andrea B Troxel; Joel M Gelfand
Journal: J Am Acad Dermatol Date: 2012-07-28 Impact factor: 11.527

Review 10. Immunology of psoriasis.

Authors: Michelle A Lowes; Mayte Suárez-Fariñas; James G Krueger
Journal: Annu Rev Immunol Date: 2014 Impact factor: 28.527